Table 2.
Circulating T-lymphocyte subsets of different patients with lung cancer (mean (±standard deviation)).
| CD3 (%) | P-value | CD4 (%) | P-value | CD8 (%) | P-value | CD4/CD8 | P-value | |
|---|---|---|---|---|---|---|---|---|
| EGFR mutation | 0.368 | 0.389 | 0.041 | 0.938 | ||||
| Positive | 67.26 (±10.90) | 37.72 (±8.77) | 24.71 (±8.69) | 1.80 (±0.98) | ||||
| Negative | 68.25 (±10.28) | 36.92 (±9.11) | 26.62 (±9.23) | 1.78 (±2.59) | ||||
| ALK rearrangement | 0.774 | 0.231 | 0.184 | 0.289 | ||||
| Positive | 67.99 (±9.18) | 35.82 (±8.95) | 27.19 (±8.08) | 1.48 (±0.74) | ||||
| Negative | 66.46 (±10.57) | 37.69 (±8.98) | 25.18 (±8.74) | 1.82 (±1.93) | ||||
| ROS-1 rearrangement | 0.768 | 0.177 | 0.334 | 0.816 | ||||
| Positive | 69.02 (±11.85) | 41.90 (±8.33) | 22.64 (±5.95) | 1.96 (±0.65) | ||||
| Negative | 67.96 (±10.58) | 37.78 (±9.03) | 25.49 (±8.77) | 1.80 (±2.04) | ||||
| PD-L1 expression | 0.834 | 0.308 | 0.075 | 0.069 | ||||
| Positive | 69.58 (±9.29) | 37.70 (±9.75) | 27.50 (±10.46) | 1.58 (±0.722) | ||||
| Negative | 69.94 (±11.72) | 39.19 (±8.64) | 24.79 (±8.68) | 1.80 (±0.792) |